Flossbach Von Storch SE boosted its stake in AMETEK, Inc. (NYSE:AME - Free Report) by 1.0% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,820,376 shares of the technology company's stock after buying an additional 36,535 shares during the quarter. AMETEK makes up about 3.1% of Flossbach Von Storch SE's holdings, making the stock its 14th biggest position. Flossbach Von Storch SE owned approximately 1.66% of AMETEK worth $784,361,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors also recently modified their holdings of AME. Darwin Wealth Management LLC acquired a new position in shares of AMETEK in the second quarter worth $25,000. CoreCap Advisors LLC boosted its position in AMETEK by 84.3% during the fourth quarter. CoreCap Advisors LLC now owns 129 shares of the technology company's stock valued at $26,000 after purchasing an additional 59 shares during the last quarter. TruNorth Capital Management LLC purchased a new position in AMETEK in the third quarter valued at about $31,000. Flagship Harbor Advisors LLC purchased a new position in AMETEK in the fourth quarter valued at about $32,000. Finally, Grey Fox Wealth Advisors LLC acquired a new position in AMETEK in the 3rd quarter worth about $39,000. Institutional investors and hedge funds own 87.43% of the company's stock.
Analyst Upgrades and Downgrades
Several brokerages have recently issued reports on AME. Morgan Stanley lifted their price target on AMETEK from $215.00 to $235.00 and gave the company an "equal weight" rating in a report on Thursday, March 12th. TD Cowen restated a "buy" rating on shares of AMETEK in a report on Tuesday, February 3rd. Wall Street Zen cut shares of AMETEK from a "buy" rating to a "hold" rating in a research note on Saturday, April 11th. DA Davidson reissued a "buy" rating and issued a $240.00 target price on shares of AMETEK in a research report on Wednesday, February 4th. Finally, Barclays increased their price target on shares of AMETEK from $210.00 to $220.00 and gave the stock an "equal weight" rating in a research note on Wednesday, February 4th. One research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $244.67.
Get Our Latest Stock Analysis on AME
Insider Activity
In related news, Director Thomas A. Amato sold 530 shares of the firm's stock in a transaction on Tuesday, March 24th. The shares were sold at an average price of $216.78, for a total value of $114,893.40. Following the transaction, the director directly owned 4,480 shares in the company, valued at approximately $971,174.40. This trade represents a 10.58% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 0.54% of the company's stock.
AMETEK Stock Performance
Shares of NYSE AME opened at $233.02 on Tuesday. The company has a debt-to-equity ratio of 0.10, a quick ratio of 0.67 and a current ratio of 1.06. The firm has a market cap of $53.38 billion, a price-to-earnings ratio of 36.41, a P/E/G ratio of 3.35 and a beta of 1.04. The business's 50-day simple moving average is $225.70 and its 200-day simple moving average is $212.19. AMETEK, Inc. has a 52 week low of $163.20 and a 52 week high of $242.05.
AMETEK (NYSE:AME - Get Free Report) last posted its earnings results on Tuesday, February 3rd. The technology company reported $2.01 earnings per share for the quarter, topping the consensus estimate of $1.94 by $0.07. The firm had revenue of $2 billion during the quarter, compared to analyst estimates of $1.94 billion. AMETEK had a return on equity of 16.55% and a net margin of 20.00%.The company's revenue for the quarter was up 13.4% on a year-over-year basis. During the same period in the previous year, the company earned $1.87 EPS. AMETEK has set its Q1 2026 guidance at 1.850-1.900 EPS and its FY 2026 guidance at 7.870-8.070 EPS. As a group, equities research analysts expect that AMETEK, Inc. will post 8.04 earnings per share for the current fiscal year.
AMETEK Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 31st. Investors of record on Monday, March 16th were issued a dividend of $0.34 per share. The ex-dividend date of this dividend was Monday, March 16th. This represents a $1.36 annualized dividend and a dividend yield of 0.6%. This is an increase from AMETEK's previous quarterly dividend of $0.31. AMETEK's payout ratio is currently 21.25%.
AMETEK Profile
(
Free Report)
AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.
The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.
See Also
Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider AMETEK, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMETEK wasn't on the list.
While AMETEK currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.
Get This Free Report